跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 70 条关于
“hematocrit”
全部
70
临床试验
35
药物
0
机构
0
资讯
35
18天前
FDA Approves MIMRYLO (rusfertide), First-in-Class Hepcidin Mimetic for Polycythemia Vera
11个月前
Silence Therapeutics Completes Enrollment in Phase 2 Trial of First-in-Class siRNA for Polycythemia Vera
6个月前
AN2 Therapeutics Expands Epetraborole Development into Phase 2 Trial for Polycythemia Vera
9个月前
Rusfertide Demonstrates Sustained Efficacy in 52-Week Polycythemia Vera Study, Supporting Regulatory Filing
去年
Silence Therapeutics Reports Promising Phase 1 Data for Divesiran in Polycythemia Vera at EHA 2025
3个月前
Deciphera Doses First Patient in Pivotal Phase 3 INTREPID Study of Sapablursen in Polycythemia Vera
去年
Novel Hepcidin Mimetic and Interferons Reshape Polycythemia Vera Treatment Landscape
5年前
FDA Grants Breakthrough Therapy Designation to Rusfertide for Polycythemia Vera
去年
Rusfertide Achieves Primary Endpoint in Phase 3 VERIFY Trial for Polycythemia Vera
去年
Ruxolitinib Maintains Long-Term Efficacy in Polycythemia Vera and Myelofibrosis Despite Emergence of Novel JAK Inhibitors
第 1 页,共 4 页
上一页
下一页